Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company City of Hope
DescriptionUniversal peptide vaccine composed of human cytomegalovirus envelope glycoprotein L (gL; UL115), human cytomegalovirus envelope glycoprotein H (gH; UL75), human cytomegalovirus uncharacterized protein UL128 (UL128), UL130 and UL131A antigens
Molecular Target Human cytomegalovirus (CMV) uncharacterized protein UL128 (UL128) ; Human cytomegalovirus (CMV) uncharacterized protein UL130 (UL130)
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationCytomegalovirus (CMV)
Indication DetailsPrevent congenital transmission of CMV; Treat and prevent cytomegalovirus (CMV)
Regulatory Designation
PartnerHelocyte Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today